On Mar. 31, 2021, Quidel announced that it had received an Emergency Use Authorization (EUA) from the U.S….
On Mar. 31, 2021, Pfizer and BioNTech announced that, in a Phase 3 trial in adolescents 12 to…
On Mar. 30, 2021, the report of the WHO international team on their Wuhan field visit, from 14…
On Mar. 30, 2021, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) granted emergency use…
On Mar. 30, 2021, OraSure Technologies announced that it had submitted an application to the U.S. Food and…
On Mar. 30, 2021, Qx Therapeutics announced that the FDA had cleared the company’s Investigational New Drug application…
On Mar. 30, 2021, CytoDyn announced further results from its CD12 trial of severe-to-critically ill patients with COVID-19….
On Mar. 29, 2021, an international research team led by Oxford University scientists announced they had developed a…
On Mar. 29, 2021, Moderna announced that the Company has shipped the 100-millionth dose of its COVID-19 vaccine…
On Mar. 29, 2021, Novavax, GSK and the UK Government Vaccines Taskforce announced an agreement in principle to…
On Mar. 29, 2021, Janssen Pharmaceutica announced that it had entered into an agreement with the African Vaccine…
On Mar. 29, 2021, CytoDyn announced that the Republic of the Philippines, Department of Health, Food and Drug…
On Mar. 25, 2021, an international team of scientists announced they had found evidence that SARS-CoV-2 infects cells…
On Mar. 25, 2021, the U.S. Department of Health and Human Services (HHS) announced the investment of $10…
On Mar. 24, 2021, AXIM Biotechnologies announced that partner Empowered Diagnostics, had filed an Emergency Use Authorization or…
On Mar. 24, 2021, Virginia Tech researchers announced that their candidate Coronavirus vaccines, prevented pigs from becoming ill…
On Mar. 24, 2021, Clover Biopharmaceuticals and Dynavax Technologies announced the first participants had been dosed in Clover’s…
On Mar. 26, 2021, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to…
On Mar. 23, 2021, Pfizer announced that it was progressing to multiple ascending doses after completing the dosing…
On Mar. 23, 2021, Omeros and Quantum Leap Healthcare Collaborative announced that dosing of patients with narsoplimab in…
On Mar. 22, 2021, the National Institutes of Health (NIH) announced that results from a large clinical trial…
On Mar. 22, 2021, Oxford University announced that a Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted…
On Mar. 22, 2021, AIM ImmunoTech announced that the Institutional Review Board (IRB) of Roswell Park Comprehensive Cancer…
On Mar. 22, 2021, Moderna announced that the Philippines had secured 7 million additional doses of COVID-19 Vaccine…
On Mar. 22, 2021, Roche confirmed positive topline results from the largest trial to date assessing a COVID-19…
On Mar. 21, 2021, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…
On Mar. 19, 2021, scientists at the University of Oxford released pre-print data measuring the level of antibodies…
On Mar. 19, 2021, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the…
On Mar. 18, 2021, AstraZeneca announced that the Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines…
On Mar. 18, 2021, Incyte announced results from the Phase 3 DEVENT study evaluating the efficacy and safety of…